Multiple outlets report that senior officials in the FDA’s tobacco center are blindsided by a recent decision that would expand the availability of certain electronic cigarettes and nicotine pouches in the U.S. market. The reporting, based on information attributed to The Associated Press, says the policy change opens the door to more products that are not authorized under current FDA review standards. The sources describe the FDA move as unexpected within the agency’s tobacco leadership, indicating that internal staff were caught off guard by the decision’s direction. MedPage Today and other outlets echo the same core account: the FDA action is linked to permitting additional electronic nicotine products that have not received full authorization. Across the coverage, the emphasis is on the internal reaction—officials being surprised by how the decision affects market access—and on the practical outcome that more unauthorized e-cigarettes and nicotine pouches may be able to enter the U.S. rather than being blocked by existing controls. The articles do not provide detailed regulatory language in the excerpts provided.